Growth Metrics

Biogen (BIIB) Non-Current Deferred Tax Liability (2016 - 2025)

Biogen (BIIB) has 17 years of Non-Current Deferred Tax Liability data on record, last reported at $358.1 million in Q3 2025.

  • For Q3 2025, Non-Current Deferred Tax Liability fell 59.42% year-over-year to $358.1 million; the TTM value through Sep 2025 reached $358.1 million, down 59.42%, while the annual FY2024 figure was $190.5 million, 70.32% down from the prior year.
  • Non-Current Deferred Tax Liability reached $358.1 million in Q3 2025 per BIIB's latest filing, up from $118.3 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $966.7 million in Q1 2021 and bottomed at $118.3 million in Q2 2025.
  • Average Non-Current Deferred Tax Liability over 5 years is $514.0 million, with a median of $571.2 million recorded in 2022.
  • Peak YoY movement for Non-Current Deferred Tax Liability: skyrocketed 310.42% in 2024, then tumbled 79.97% in 2025.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $694.5 million in 2021, then plummeted by 51.81% to $334.7 million in 2022, then soared by 91.75% to $641.8 million in 2023, then crashed by 70.32% to $190.5 million in 2024, then surged by 87.98% to $358.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $358.1 million in Q3 2025, $118.3 million in Q2 2025, and $133.2 million in Q1 2025.